AzTrials
AzTrials

Hypoxic Ischemic Encephalopathy of NewbornNCT06950723

Chest Physical Therapy on Arterial Blood Gases for Neonates Post Hypoxic Ischemic Encephalopathy

A study testing Chest Physical Therapy (CPT) modalities , Medical Treatment in people with Hypoxic Ischemic Encephalopathy of Newborn, run by Cairo University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Hypoxic-ischemic encephalopathy (HIE) is a dangerous illness that happens when a newborn's brain does not receive adequate oxygen and blood flow, which can result in serious effects such as cerebral palsy and epilepsy. Infant diagnosed with HIE required ventilator support and subsequently developed pneumonia. Read more about this study

Who is it for?
Ages 1 day to 10 days
What is being tested?
Chest Physical Therapy (CPT) modalities , Medical Treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
No sites listed yet
Study dates
10 May 2025to 15 Jul 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 10 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Neonates with chest problems post Hypoxic-ischemic encephalopathy

Who cannot join

  • Neonates with chest problems due to other Causes except post Hypoxic-ischemic encephalopathy.
  • unstable medical status
  • Neonates with Post-operative s' respiratory problems due to any reasons.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Elsayed Mehrem, Associate Professor contact

+201006973334

sayed7555@yahoo.com

About this study

Official title: Efficacy of Chest Physical Therapy on Arterial Blood Gases for Neonates Post Hypoxic Ischemic Encephalopathy in Neonatal Intensive Care Unit: A Clinical Trial Study

Hypoxic-ischemic encephalopathy (HIE) is a dangerous illness that happens when a newborn's brain does not receive adequate oxygen and blood flow, which can result in serious effects such as cerebral palsy and epilepsy. Infant diagnosed with HIE required ventilator support and subsequently developed pneumonia. They experienced respiratory problems and feeding challenges. Chest Physical Therapy is the best modalities to clear chest and improve ventilation.

Read the detailed description

The purpose of this study to investigate the effect of chest physical therapy on Arterial Blood Gases for neonates post hypoxic ischemic encephalopathy (HIE) in Neonatal intensive care unit.

Methods: Fifty neonates from both sexes, age from birth to 10 days, post HIE with chest problems were selected from neonatal intensive care unit (NICU) at Minia University hospital, Egypt. They were divided into two equal groups, control group (CG) received traditional medical treatment according to American Academy of Pediatrics (AAP) recommendations and study group (SG) received traditional medical treatment plus Chest Physical Therapy (CPT) modalities in the form of postural drainage, percussion and vibration. The sessions will apply once daily for 6 days/week, each session is about 30 minutes, according to the neonate tolerance till complete clinical cure and discharge from NICU.

the outcome will measure by Timing of Arterial blood gases improvement, Duration required for clinical improvement, Duration of Mechanical ventilation, Duration of Hospitalization.

Being tested
Chest Physical Therapy (CPT) modalities , Medical Treatment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Chest Physical Therapy (CPT) modalities , Medical TreatmentOther

    Chest Physical Therapy (CPT) modalities in the form of postural drainage, percussion and vibration.

Study groups in NCT06950723
Study groupRoleWhat they receive
Chest physical Therapy groupExperimentalStudy group
Receives: Other: Chest Physical Therapy (CPT) modalities , Medical Treatment
Medical treatment groupExperimentalControl group
Receives: Other: Chest Physical Therapy (CPT) modalities , Medical Treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Timing of Arterial blood gases improvement

    Time needed to improve Arterial blood gases due to CPT

    Measured: 3-14 days

  2. Timing required for clinical improvement

    Time needed to improve clinical signs due to CPT

    Measured: 3-14 days

  3. Timing needed for Mechanical Ventilation

    Time needed to Mechanical Ventilation support.

    Measured: 3-7 days

  4. Hospitalization time

    All staying duration need for the neonates from admission till discharge from the hospital.

    Measured: 5-21 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2025
  2. Study start10 May 2025 (estimated)
  3. Primary completion10 Jun 2025 (estimated)
  4. Study completion15 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06950723
Sponsor's protocol ID
Sayed75
Status last verified
Apr 2025
First submitted
9 Apr 2025
Last updated
30 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Chest Physical Therapy (CPT) modalities , Medical Treatment in people with Hypoxic Ischemic Encephalopathy of Newborn, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 30 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Elsayed Mehrem, Associate Professor (+201006973334, sayed7555@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Timing of Arterial blood gases improvement (time frame: 3-14 days). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in